Mumbai, Oct. 21 -- Jubilant Pharmova announced that India Ratings and Research has assigned the credit rating IND AA+; Stable to the company's proposed non-convertible debentures of Rs 1400 crore.

Published by HT Digital Content Services with permission from Capital Market....